Alice S. Cheung

Singapore, Singapore

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 23 publications

γδ T-cells in human malignancies: insights from single-cell studies and analytical considerations.

γδ T-cells in human malignancies: insights from single-cell studies and analytical considerations.

Journal: Frontiers in immunology

Published: May 27, 2024

Rapid disease progression of myelodysplastic syndrome is reflected in transcriptomic and functional abnormalities of bone marrow mesenchymal stromal cells.

Rapid disease progression of myelodysplastic syndrome is reflected in transcriptomic and functional abnormalities of bone marrow mesenchymal stromal cells.

Journal: Stem cells (Dayton, Ohio)

Published: April 01, 2024

Superoxide-mediated phosphorylation and stabilization of Mcl-1 by AKT underlie venetoclax resistance in hematologic malignancies.

Superoxide-mediated phosphorylation and stabilization of Mcl-1 by AKT underlie venetoclax resistance in hematologic malignancies.

Journal: Leukemia

Published: July 11, 2023

Cord blood-derived Vδ2+ and Vδ2- T cells acquire differential cell state compositions upon in vitro expansion.

Cord blood-derived Vδ2+ and Vδ2- T cells acquire differential cell state compositions upon in vitro expansion.

Journal: Science advances

Published: June 16, 2023

Editorial: Next generation γδ T cell-based tumor immunotherapy.

Editorial: Next generation γδ T cell-based tumor immunotherapy.

Journal: Frontiers in immunology

Published: September 10, 2022

A single-cell atlas identifies pretreatment features of primary imatinib resistance in chronic myeloid leukemia.

A single-cell atlas identifies pretreatment features of primary imatinib resistance in chronic myeloid leukemia.

Journal: Blood

Published: June 07, 2022

Dampened Inflammation and Improved Survival After CXCL5 Administration in Murine Lupus via Myeloid and Neutrophil Pathways.

Dampened Inflammation and Improved Survival After CXCL5 Administration in Murine Lupus via Myeloid and Neutrophil Pathways.

Journal: Arthritis & rheumatology (Hoboken, N.J.)

Published: January 23, 2022

Effective Killing of Acute Myeloid Leukemia by TIM-3 Targeted Chimeric Antigen Receptor T Cells.

Effective Killing of Acute Myeloid Leukemia by TIM-3 Targeted Chimeric Antigen Receptor T Cells.

Journal: Molecular cancer therapeutics

Published: February 26, 2020

Correction: Bone marrow MSCs in MDS: contribution towards dysfunctional hematopoiesis and potential targets for disease response to hypomethylating therapy.

Correction: Bone marrow MSCs in MDS: contribution towards dysfunctional hematopoiesis and potential targets for disease response to hypomethylating therapy.

Journal: Leukemia

Published: February 22, 2019

Bone marrow MSCs in MDS: contribution towards dysfunctional hematopoiesis and potential targets for disease response to hypomethylating therapy.

Bone marrow MSCs in MDS: contribution towards dysfunctional hematopoiesis and potential targets for disease response to hypomethylating therapy.

Journal: Leukemia

Published: July 20, 2018

Mesenchymal Stromal Cell (MSC)-Derived Combination of CXCL5 and Anti-CCL24 Is Synergistic and Superior to MSC and Cyclosporine for the Treatment of Graft-versus-Host Disease.

Mesenchymal Stromal Cell (MSC)-Derived Combination of CXCL5 and Anti-CCL24 Is Synergistic and Superior to MSC and Cyclosporine for the Treatment of Graft-versus-Host Disease.

Journal: Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation

Published: February 23, 2018

HoxC5 and miR-615-3p target newly evolved genomic regions to repress hTERT and inhibit tumorigenesis.

HoxC5 and miR-615-3p target newly evolved genomic regions to repress hTERT and inhibit tumorigenesis.

Journal: Nature communications

Published: May 04, 2017

Showing 1-12 of 23

Last Updated: 09/26/2026